Mode
Text Size
Log in / Sign up
N/A N=107

Image Evaluation of Philips Philips MammoDiagnost DR Full Field Digital Mammography System (FFDM)

Breast Cancer

Enrolled (actual)
107
Serious AEs
0.0%
Results posted
May 2012
Primary outcome: Primary: FFDM (Full Field Digital Mammography) Mammogram Scores — 12; 0 FFDM Mammogram set

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult, Older Adult · 40+ yrs
Sex
Female
Sponsor
Philips Healthcare
Primary completion
Jan 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
FFDM (Full Field Digital Mammography) Mammogram Scores
12; 0

Summary

The purpose of this investigation, using hardcopy film, is to compare the accuracy of the Philips MammoDiagnost DR (FFDM device) and screen-film (SF) mammography in detection of breast cancer among women undergoing screening or diagnostic mammography. Per the new FDA Guidance document for FFDM, accuracy in comparison to Screen-film is no longer required.

Eligibility Criteria

Inclusion Criteria

  • Patient underwent or is scheduled to undergo a screening or diagnostic mammogram examination (right and left craniocaudal and mediolateral oblique with or without special views) at one of the acquisition centers during the course of this research study.
  • At least 40 years of age
  • Provides written informed consent indicating willingness to participate in this research study prior to performance of the Philips FFDM mammogram
  • Meets none of the exclusion criteria

Exclusion Criteria

  • Presence of a breast implant,
  • Patients undergoing a unilateral mammogram or an incomplete SF mammogram
  • had previously undergone an excisional breast biopsy
  • Pregnant women or patients who believe they may be pregnant

(f) Inmates (in accordance with 45 CFR 46.306)

(g) Patients who cannot, for any reason, undergo follow-up mammography examinations (where clinically indicated) at the participating institution

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00999596). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search